Abstract

To the Editor .—Angiotensin-converting enzyme inhibitors have been regarded as safe medications for the treatment of hypertension. Adverse reactions of these drugs have been minimal except for the recent recognition of angiotensin-converting enzyme inhibitor—associated edema. 1,2 The incidence of angioedema with these medications has been estimated to be less than 0.5%. 3 There has been recent interest in both the medicine and otolaryngology—head and neck surgery literature concerning this complication. We present a patient who had a delayed episode of angioedema 24 months after the initiation of enalapril. In March 1991, a 56-year-old woman presented to the emergency department with shortness of breath and inability to handle her secretions. Physical examination revealed edema involving the base of tongue, floor of mouth, and posterior aspect of the pharynx. The patient was treated with intravenous diphenhydramine, subcutaneous heparin, and supplemental oxygen. Emergent fiberoptic endotracheal intubation was performed to secure the patient's

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.